Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Low-dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.

Autor: Sriranjan R; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK rfss2@cam.ac.uk., Zhao TX; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Tarkin J; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Hubsch A; Department of Medicine, Division of Experimental Medicine and Immunotherapeutics (EMIT), University of Cambridge, Cambridge, UK., Helmy J; Department of Medicine, Division of Experimental Medicine and Immunotherapeutics (EMIT), University of Cambridge, Cambridge, UK., Vamvaka E; Department of Medicine, Division of Experimental Medicine and Immunotherapeutics (EMIT), University of Cambridge, Cambridge, UK., Jalaludeen N; Department of Medicine, Division of Experimental Medicine and Immunotherapeutics (EMIT), University of Cambridge, Cambridge, UK., Bond S; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Hoole SP; Cardiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK., Knott P; Department of Clinical Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Buckenham S; Department of Clinical Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Warnes V; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bird N; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Cheow H; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Templin H; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Cacciottolo P; Department of Medicine, Division of Experimental Medicine and Immunotherapeutics (EMIT), University of Cambridge, Cambridge, UK., Rudd JHF; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Mallat Z; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Cheriyan J; Department of Medicine, Division of Experimental Medicine and Immunotherapeutics (EMIT), University of Cambridge, Cambridge, UK.

Publikováno v: BMJ open [BMJ Open] 2022 Oct 07; Vol. 12 (10), pp. e062602. Date of Electronic Publication: 2022 Oct 07.

A zero coronary artery calcium score in patients with stable chest pain is associated with a good prognosis, despite risk of non-calcified plaques

Autor: Wang, Xue, Le, Elizabeth, Rajani, N, Hudson-Peacock, N, Pavey, Holly, Tarkin, J, Babar, J, Williams, Michelle, Gopalan, D, Rudd, JHF

Publikováno v: Open Heart
Wang, X, LE, EPV, Rajani, NK, Hudson-Peacock, NJ, Pavey, H, Tarkin, JM, Babar, J, Williams, M, Gopalan, D & Rudd, JHF 2019, ' A zero coronary artery calcium score in patients with stable chest pain is associated with a good prognosis despite risk of non-calcified plaques ', Open heart . https://doi.org/10.1136/openhrt-2018-000945

OBJECTIVES: To estimate the prevalence of non-calcified coronary artery disease (CAD) in patients with suspected stable angina and a zero coronary artery calcium (CAC) score, and to assess the prognostic significance of a zero CAC in these symptomati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cb84cb4b72af9ae93451ac81e29a41
http://europepmc.org/articles/PMC6519430

Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation.

Autor: Bargehr J; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Rericha P; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Petchey A; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Colzani M; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Moule G; Department of Histopathology, Royal Papworth Hospital, Cambridge, UK., Malgapo MC; Department of Histopathology, Royal Papworth Hospital, Cambridge, UK., Rassl D; Department of Histopathology, Royal Papworth Hospital, Cambridge, UK., Tarkin J; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Mellor G; Cardiology Department, Royal Papworth Hospital, Cambridge, UK., Sampaziotis F; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Hepatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Brevini T; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Gambardella L; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Bennett MR; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Sinha S; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK.

Publikováno v: ESC heart failure [ESC Heart Fail] 2021 Oct; Vol. 8 (5), pp. 4119-4129. Date of Electronic Publication: 2021 Aug 12.